Overview

Effects of Alanine in Patients With Nonalcoholic Steatohepatitis

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Purpose of this study is to assess the therapeutic efficacy of L-alanine in improving biological and histological findings by administrating 6-18g/day L-alanine for one year. We will also assess the safety and toxicity profile of long-term administration of L-alanine.
Phase:
N/A
Details
Lead Sponsor:
Keith D Lindor, M.D.
Collaborator:
Ajinomoto USA, INC.